Blanca A-G
@blanka-g.bsky.social
📤 17
📥 49
📝 4
@eye-tuebingen.bsky.social
Congratulations to our student Katharina Kock on receiving the 1st Poster Prize from the Faculty of Medicine at the University of Tübingen! Very proud to see her excellent work on retinal degeneration and VCP recognized. A truly well-deserved achievement. 🎉
about 2 months ago
0
1
0
Happy to share our new article in Journal of Controlled Release on the protective effect of VCP inhibition on retinal degeneration Congratulations to our student Bowen Cao for her excellent work, and many thanks to all coauthors for the great collaboration.
www.sciencedirect.com/science/arti...
loading . . .
Ocular delivery of different valosin-containing protein (VCP) inhibitory formulations prevents retinal degeneration in rho∆I255 mice
Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) is a progressive inherited retinal degenerative disorder currently lacking effec…
https://www.sciencedirect.com/science/article/pii/S0168365926000714
5 months ago
0
1
0
reposted by
Blanca A-G
Institute for Ophthalmic Research in Tübingen
5 months ago
For PhD studs, postdocs. Cutting-edge retina research, from physiology to disease mechanisms. Strong involvement from IOR in Tübingen, highlighting commitment to training the next generation of vision scientists!
@blanka-g.bsky.social
@unituebingen.bsky.social
www.eye-tuebingen.de?tx_news_pi1%...
loading . . .
Retina in a Dish: Advanced Ex-Vivo Methods for Retina Research
The active representation of the Institute for Ophthalmic Research in Tübingen, represents the strategic focus on retina physiology and disease mechanisms, as well as its commitment to training the ne...
https://www.eye-tuebingen.de/?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=206&cHash=f948dba5d3c3d2ece161ee82407b6497
1
1
2
Excited to share that our research is now published! Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors! 🔗
link.springer.com/article/10.1...
@eye-tuebingen.bsky.social
#Proteostasis
#VCP
#RetinalDegeneration
#PreclinicalResearch
loading . . .
Safety and neuroprotective efficacy of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo study - BMC Medicine
Background Retinal degenerative diseases represent a complex global health problem due to their significant impact on patients’ daily lives and their highly heterogeneous pathogenesis, which challenge...
https://link.springer.com/article/10.1186/s12916-025-04610-0
6 months ago
0
0
0
you reached the end!!
feeds!
log in
